Tumor Stem Cells
Fraunhofer Institute for Cell Therapy and Immunology IZI
- © Dirk Mahler / Fraunhofer
The objective of the unit is to develop therapeutic strategies for the treatment of neoplastic disease which are based both on living cells as well as on pharmaceutically active ingredients. The foundation for these approaches is the elimination or modification of tumor stem cells (TSCs) in the targeted malignancy. Using the TSC concept, further TSC should be described and therapeutic innovations in the field of internal oncology will be made possible.